24 jul: Bobler fra dybet fik hammerslag på rekordpriser ved nyligt afhold..
01 aug: Mercedes CLS Shooting Brake på vej til Danmark
30-07-2012 08:45:00

Reckitt Benckiser Warns on Mature Markets as Profit Rises

Relateret indhold

By Simon Zekaria

LONDON--Reckitt Benckiser PLC (RB.LN) Monday warned on a tough outlook for consumer spending in mature markets as it posted a slight rise in profit, helped by demand for household and medical products in emerging markets.

"While the consumer and competitive environment in Europe and North America remains challenging, we are doing the right things for the long term," said Chief Executive Rakesh Kapoor.

The U.K.-based maker of Air Wick air freshener, Dettol disinfectant and Neurofen pain relief tablets said net profit in the six months to June 30 rose 2.6% to GBP779 million ($1.22 billion) from GBP759 million a year earlier. Revenue in the period rose to GBP4.67 billion from GBP4.62 billion.

Second-quarter revenue fell 1.1% to GBP2.31 billion from GBP2.34 billion, missing market expectations from a company poll of GBP2.35 billion. However, like-for-like revenue rose 4%.

Unilever NV (UN) last week warned consumer companies are operating in a deteriorating global economy as it reported a small drop in net profit, while U.S.-based market leader Procter & Gamble Co. (PG) has issued two profit warnings this year, blaming weak demand in mature markets where spending is squeezed.

Rising middle-class populations with increased spending power in countries like Brazil, India and Indonesia are driving demand for high-margin health and hygiene goods. In contrast, Western economies, particularly in Europe, are seeing a cutback in consumer purchases amid weak economic conditions.

Earlier this year, Reckitt announced plans to merge its North American and European operations in a bid to focus investment and resources in emerging markets. Its goal is to generate half of its sales in developing economies, excluding food and pharmaceuticals, by 2016, up from just over 40% currently.

The move is aimed at reversing a recent slowdown in business. Last year saw the departure of CEO Bart Becht, the man credited with delivering consistent profit growth and more than quadrupling the company's share price since taking over in 1999. His replacement, Mr. Kapoor, is now tasked with guiding the company through an increasingly turbulent market.

Slough, England-based Reckitt Benckiser, which makes products as diverse as French's yellow mustard and Suboxone, a heroin addiction treatment, is aiming for comparable full-year revenue, excluding its pharmaceutical operations, to exceed forecast market growth of 1% to 2% by two percentage points, and to sustain this trajectory in the medium term. Excluding pharmaceuticals, it aims to maintain its operating margins.

It recommended an interim dividend of 56 pence a share, up 2% year-on-year.

Reckitt Benckiser shares closed Friday at 3542 pence, valuing the company at GBP25.61 billion, up 11% in the year to date.

Write to Simon Zekaria at simon.zekaria@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 30, 2012 02:45 ET (06:45 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
20 feb
E:RB.
Ja, desværre kite, men måske han læser alligevel, og man kan jo håbe, at han "besinder" sig og lærer..
1

Fondsbørsmeddelelser

Aktier/tendens: William Demant kan tage fokus i grøn åbning

23-02-2018 08:27:52
Der er udsigt til stigninger fredag morgen, når aktiemarkedet herhjemme åbner. Fra åbningen kan William Demant igen tage fokus, efter at selskabet har fået hævet kursmålet af en stribe finanshuse ovenpå torsdagens positive regnskab. I USA lukkede S&P 500 torsdagens handel med et plus på 0,2 pct., mens også Dow Jones lukkede med en gevinst på 0,7 pct. Til gengæld faldt Nasdaq med 0,1 pct. Futures f..

Aktier/middag: Genmab buldrer frem med WDH og ISS som følgesvende

22-02-2018 11:40:57
Biotekselskabet Genmab ligger helt i top i det danske eliteindeks torsdag middag efter at have præsenteret regnskab onsdag aften. Også ISS og William Demant, der begge kom med regnskab for fjerde kvartal torsdag morgen, er med i toppen.Men det er onsdagens regnskab fra Genmab, der trækker den helt store opmærksomhed, efter at biotekselskabet gjorde markedets bekymringer over en mulig skuffende pro..

ISS: Salget vokser mens bundlinjen skrumper

22-02-2018 08:39:00
ISS kan se bundlinjen falde tilbage i 2017 sammenlignet med i 2016, selvom selskabet er vokset på salget.Omsætningen i selskabet voksede til 79.912 mio. kr. i 2017, mens omsætningen udgjorde 78.658 mio. kr. i 2016.Omvendt steg nettoresultatet i 2017 til 2007 mio. kr. mod 2220 mio. kr. året før.Af regnskabet fremgår det, at årsagen til at bundlinjen ikke vokser med toplinjen, blandt andet er ekster..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Genmab og Novo udvider samarbejde - citat
2
Nilfisk-konkurrent afviser fusion - aktien falder tungt - NY
3
Novo/Redburn: Hæver anbefalingen til "køb" fra "neutral"
4
Aktier/tendens: William Demant kan tage fokus i grøn åbning
5
Pandora-næstformand udnytter 16.008 aktieoptioner

Relaterede aktiekurser

Unilever PLC ORD 3 1/9P 3.760,50 0,0% Aktiekurs uændret
Procter & Gamble Company.. 81,05 0,0% Aktiekurs uændret
Unilever NV 53,45 0,0% Aktiekurs uændret
Unilever PLC 52,68 0,0% Aktiekurs uændret
Reckitt Benckiser Group .. 5.918,10 0,0% Aktiekurs uændret
Unilever DR 43,49 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. februar 2018 07:12:24
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseBuild_20180222.1 - EUROWEB3 - 2018-02-24 07:12:24 - 2018-02-24 07:12:24 - 1 - Website: OKAY